Atlas Trials

Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

Clinical trial NCT02882893 · UNKNOWN

Trial details

NCT number
NCT02882893
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Crows Feet Lines
Start date
2016-08-01
Primary completion
2017-01-01
Enrollment
238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.